Alternative models for carcinogenicity testing.
暂无分享,去创建一个
S. Cohen | D. Robinson | S M Cohen | J. MacDonald | D Robinson | J MacDonald | J. Macdonald | S. M. Cohen | James W. MacDonald
[1] S. Johansson,et al. Uroepithelial tumors of the renal pelvis associated with abuse of phenacetin‐containing analgesics , 1974, Cancer.
[2] I. Purchase,et al. Workshop Overview: Scientific and Regulatory Challenges for the Reduction, Refinement, and Replacement of Animals in Toxicity Testing 1 , 1998 .
[3] R. Tennant,et al. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. , 1995, Environmental health perspectives.
[4] I. Purchase,et al. Workshop overview: scientific and regulatory challenges for the reduction, refinement, and replacement of animals in toxicity testing. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.
[5] R. Tennant,et al. Review Article: Use of Transgenic Animals for Carcinogenicity Testing: Considerations and Implications for Risk Assessment , 2000 .
[6] J. P. Van Oosterhout,et al. The utility of two rodent species in carcinogenic risk assessment of pharmaceuticals in Europe. , 1997, Regulatory toxicology and pharmacology : RTP.
[7] A. Monro,et al. Marketed Human Pharmaceuticals Reported to be Tumorigenic in Rodents , 1995 .
[8] D. Rall. LABORATORY ANIMAL TESTS AND HUMAN CANCER* , 2000, Drug metabolism reviews.
[9] P Fenner-Crisp,et al. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? , 1998, Regulatory toxicology and pharmacology : RTP.
[10] P. Fu,et al. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay. , 1997, Regulatory toxicology and pharmacology : RTP.
[11] R. Maronpot,et al. Rodent Carcinogenicity Bioassay: Past, Present, and Future , 1994, Toxicologic pathology.
[12] J. Contrera,et al. Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals. , 1997, Regulatory toxicology and pharmacology : RTP.